middle.news
ResMed Posts 10% Revenue Growth and 65% Net Income Surge in Q2 2024
5:50pm on Sunday 1st of June, 2025 AEST
•
Healthcare
Read Story
ResMed Posts 10% Revenue Growth and 65% Net Income Surge in Q2 2024
5:50pm on Sunday 1st of June, 2025 AEST
Key Points
10% year-over-year net revenue growth to $1.28 billion
65% increase in net income to $344.6 million for Q2 2024
Gross margin improved to 58.6%, up from 55.6% in prior year
Continued investment in R&D at 6.3% of net revenues
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resmed (ASX:RMD)
OPEN ARTICLE